The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
406 jobs Number of planned job losses
Announcement Date
21 March 2017
Employment effect (start)
21 March 2017
Foreseen end date
31 December 2018
Description
On 21 March 2017, German pharma company Mundipharma announced to cut over 400 jobs in Germany by the end of 2018. The company will close its headquarter in Limburg. Background to the job cuts, is the low utilisation of production capacities in Limburg. The company’s management decided to bundle its marketing and sales activities in Cambridge, UK. Manufacturing and packaging of drugs will be outsourced to contracted companies.
The company currently employs 770 staff in Germany.
Sources
22 March 2017: Frankfurter Allgemeine
22 March 2017: hessenschau.de
Citation
Eurofound (2017), Mundipharma, Closure in Germany, factsheet number 90571, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/90571.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
